SYNTENY BIOTECHNOLOGY LIMITEDActive
Key figures
Like most small UK companies, SYNTENY BIOTECHNOLOGY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025/26Balance sheet structure
Filed accounts2021/22–2025/26
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 714,273 | 1,388,943 | 885,809 | 287,524 | 232,306 |
| Total assets | 730,133 | 1,588,658 | 1,410,912 | 1,481,471 | 1,855,321 |
| Total liabilities | — | 53,288 | 2,678,486 | — | — |
| Net assets / total equity | 50,001 | 1,535,370 | -1,267,574 | -1,890,177 | -4,638,654 |
| Average number of employees | 3 | 7 | 13 | 13 | 16 |
| Average pay (per year) | — | — | 83,617 | — | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: SYNTENY BIOTECHNOLOGY LIMITED
Company
SYNTENY BIOTECHNOLOGY LIMITED is a private limited company registered with Companies House under company number 13408581. It was incorporated on 19 May 2021. Its status is active. The registered office is in London (WC2B). Its nature of business (SIC 2007) is business and domestic software development (62012).
Accounts
The latest accounts in the database are for 2025/26 (period ending 31 Jan 2026); the company files small company accounts (filleted). Net assets were −£4,638,654, down 145.4% on the previous year. Cash at bank and in hand was £232,306. The company had an average of 16 employees. Figures are available for 5 financial years (2021/22–2025/26).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Oct 2027. The next confirmation statement is due by 28 Nov 2026.